Should You Buy BP plc And GlaxoSmithKline plc For Your Income Portfolio?

BP plc (LON:BP) and GlaxoSmithKline plc (LON:GSK) fall under this Fool’s scrutiny.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

In years gone by, BP (LSE: BP) and GlaxoSmithKline (LSE: GSK) would have been automatic inclusions to income-seeking portfolios. The two companies are FTSE heavyweights, the 5th and 6th biggest companies listed on the London Stock Exchange respectively. Recent share price weakness has moved the yields on both shares north of 6%, and both companies should be seriously considered for high-yielding portfolios. 

BP

Shares in BP have been under pressure recently due to the latest commodity sell-off. Currently they yield a huge 7.91% due to the tough industry environment that the company operates in. This high yield is backed up by an expected 2015 dividend cover of 0.88 and a divestment strategy aimed at selling over $10 billion worth of non-core assets. In its most recent quarterly results (Q2), BP had operating cashflows of $6.3 billion and over $33 billion of cash and short-term investments on the balance sheet. This is a strong cash-generating business that can afford to keep the dividend well into the future, even at a $50 oil price. This could be an especially good time to buy BP shares, too, as buying now will lock in the 7.91% yield, even if oil prices continue to recover and BP shares rise up to the 400-500p level. 

GlaxoSmithKline

Although in a completely different sector to BP, GlaxoSmithKline shares have also been under pressure recently and its shares are down over 350p since year-highs in May. Currently the company has a yield of 6.32% and a dividend cover of 0.83, not much different to that of BP. Many financial analysts would say that GlaxoSmithKline’s yield will be slashed in the next year but, like BP, they are a heavily cash-generative business and can afford the dividend. The really exciting part of the company is that of pipeline of over 200 new drugs and treatments, the company expect half of them will hit the market in the next five years and will boost company earnings. This pipeline of new products is what attracts investors to pharmaceutical stocks and can send their stock prices through the roof. AstraZeneca (LSE: AZN), another FTSE 100 stock yielding over 4%, was subject to much takeover speculation and eventually takeover offer due to its pipeline of new drugs. This growth potential backed up by a strong dividend is what makes GlaxoSmithKline so attractive to investors. 

Even if BP and GlaxoSmithKline cut their dividends, they would still be among the top 20 yielding stocks in the FTSE 100 and both have better growth prospects than many, in my opinion.


Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jack Dingwall has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

ISA Individual Savings Account
Investing Articles

How to build a Stocks and Shares ISA with a 6% dividend yield

It’s easy to build an investment portfolio with a high dividend yield today. But investors need to manage risk carefully,…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

How risky is switching from cash savings to a Stocks and Shares ISA?

The UK government is making moves to encourage cash savers to consider investing via Stocks and Shares ISAs. But what…

Read more »

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

4,985 shares of this FTSE dividend star pay an income equal to the State Pension!

Zaven Boyrazian calculates how many shares investors would have to buy to generate enough income to match the UK State…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

£500 buys me 407 shares in this 8.2%-yielding income stock!

Got a small lump sum? Zaven Boyrazian explores one underappreciated income stock offering an enormous yield that could be set…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

Up 23% this year, is it too late to buy shares in this FTSE 100 compounder?

Having missed Diploma shares at £36 back in April, is a strong trading update with higher guidance a good enough…

Read more »

Businessman hand flipping wooden block cube from 2024 to 2025 on coins
Investing Articles

Does this ex-penny stock have the potential to almost double?

This under-the-radar mining stock has doubled in the last 12 months, lifting it out of penny stock territory. But could…

Read more »

A mature adult sitting by a fireplace in a living room at home. She is wearing a yellow cardigan and spectacles.
Investing Articles

£5k in savings? Here’s how that can unlock a £255 monthly second income

Ever wondered how to turn a lump sum of savings into a chunky second income? Zaven Boyrazian explains a simple…

Read more »

British pound data
Investing Articles

Get ready for a US stock market crash?

Experts are waving the red flag on the US stock market and economy, warning of an impending crash. Should investors…

Read more »